MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

Search

IQVIA Holdings Inc

Avatud

SektorTervishoid

207.67 1.95

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

201.41

Max

207.47

Põhinäitajad

By Trading Economics

Sissetulek

17M

266M

Müük

188M

4B

P/E

Sektori keskmine

29.532

36.442

Kasumimarginaal

6.622

Töötajad

90,000

EBITDA

28M

781M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+7.99% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

28. okt 2025

Turustatistika

By TradingEconomics

Turukapital

7.1B

35B

Eelmine avamishind

205.72

Eelmine sulgemishind

207.67

Uudiste sentiment

By Acuity

50%

50%

166 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

IQVIA Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. okt 2025, 23:25 UTC

Suurimad hinnamuutused turgudel

Salesforce Rises on New FY30 Financial Targets

15. okt 2025, 18:52 UTC

Tulu
Suurimad hinnamuutused turgudel

Prologis Shares Gain on Raised Outlook, Data Center Growth

15. okt 2025, 18:30 UTC

Omandamised, ülevõtmised, äriostud

Constellation Software to Buy U.K.'s Tecvia Holding

15. okt 2025, 17:19 UTC

Omandamised, ülevõtmised, äriostud

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15. okt 2025, 17:11 UTC

Omandamised, ülevõtmised, äriostud

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15. okt 2025, 23:48 UTC

Market Talk

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15. okt 2025, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15. okt 2025, 22:37 UTC

Market Talk

Economic Stars Are Aligning for RBA -- Market Talk

15. okt 2025, 21:44 UTC

Tulu

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15. okt 2025, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

15. okt 2025, 20:44 UTC

Omandamised, ülevõtmised, äriostud

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15. okt 2025, 20:44 UTC

Omandamised, ülevõtmised, äriostud

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15. okt 2025, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15. okt 2025, 20:34 UTC

Tulu

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15. okt 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15. okt 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15. okt 2025, 19:06 UTC

Tulu

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15. okt 2025, 19:04 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

15. okt 2025, 18:46 UTC

Market Talk

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15. okt 2025, 18:23 UTC

Tulu

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15. okt 2025, 17:37 UTC

Omandamised, ülevõtmised, äriostud

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15. okt 2025, 17:34 UTC

Market Talk

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15. okt 2025, 16:57 UTC

Tulu

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15. okt 2025, 16:51 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Doesn't Disclose Financial Details

15. okt 2025, 16:50 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15. okt 2025, 16:49 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15. okt 2025, 16:48 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15. okt 2025, 16:48 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15. okt 2025, 16:47 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Buys Ikerian

15. okt 2025, 16:34 UTC

Market Talk

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Võrdlus sarnastega

Hinnamuutus

IQVIA Holdings Inc Prognoos

Hinnasiht

By TipRanks

7.99% tõus

12 kuu keskmine prognoos

Keskmine 221.13 USD  7.99%

Kõrge 240 USD

Madal 200 USD

Põhineb 18 Wall Streeti analüütiku instrumendi IQVIA Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

14

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

150.68 / 153.45Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

166 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat